Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Outcomes of adjuvant radiotherapy and lymph node resection in elderly patients with pancreatic cancer treated with surgery and chemotherapy.

Frakes J, Mellon EA, Springett GM, Hodul P, Malafa MP, Fulp WJ, Zhao X, Hoffe SE, Shridhar R, Meredith KL.

J Gastrointest Oncol. 2017 Oct;8(5):758-765. doi: 10.21037/jgo.2017.08.05.

2.

Resection of Gastrointestinal Metastases in Stage IV Melanoma: Correlation with Outcomes.

Prabhakaran S, Fulp WJ, Gonzalez RJ, Sondak VK, Kudchadkar RR, Gibney GT, Weber JS, Zager JS.

Am Surg. 2016 Nov 1;82(11):1109-1116.

PMID:
28877811
3.

Resection of Gastrointestinal Metastases in Stage IV Melanoma: Correlation with Outcomes.

Prabhakaran S, Fulp WJ, Gonzalez RJ, Sondak VK, Kudchadkar RR, Gibney GT, Weber JS, Zager JS.

Am Surg. 2016 Nov 1;82(11):1109-1116.

PMID:
28206940
4.

A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.

Scott JG, Berglund A, Schell MJ, Mihaylov I, Fulp WJ, Yue B, Welsh E, Caudell JJ, Ahmed K, Strom TS, Mellon E, Venkat P, Johnstone P, Foekens J, Lee J, Moros E, Dalton WS, Eschrich SA, McLeod H, Harrison LB, Torres-Roca JF.

Lancet Oncol. 2017 Feb;18(2):202-211. doi: 10.1016/S1470-2045(16)30648-9. Epub 2016 Dec 18.

PMID:
27993569
5.

Country-specific HPV-related genital disease among men residing in Brazil, Mexico and The United States: The HIM study.

Sudenga SL, Torres BN, Fulp WJ, Silva R, Villa LL, Lazcano-Ponce E, Ingles DJ, Stoler M, Messina JL, Abrahamsen M, Baggio ML, Salmeron J, Quiterio M, Giuliano AR.

Int J Cancer. 2017 Jan 15;140(2):337-345. doi: 10.1002/ijc.30452. Epub 2016 Oct 20.

6.

An analysis of HPV infection incidence and clearance by genotype and age in men: The HPV Infection in Men (HIM) Study.

Ingles DJ, Lin HY, Fulp WJ, Sudenga SL, Lu B, Schabath MB, Papenfuss MR, Abrahamsen ME, Salmeron J, Villa LL, Ponce EL, Giuliano AR.

Papillomavirus Res. 2015 Dec;1:126-135. Epub 2015 Oct 8.

7.

Outcomes of a Clinical Pathway for Borderline Resectable Pancreatic Cancer.

Rashid OM, Pimiento JM, Gamenthaler AW, Nguyen P, Ha TT, Hutchinson T, Springett G, Hoffe S, Shridhar R, Hodul PJ, Johnson BL, Illig K, Armstrong PA, Centeno BA, Fulp WJ, Chen DT, Malafa MP.

Ann Surg Oncol. 2016 Apr;23(4):1371-9. doi: 10.1245/s10434-015-5006-1. Epub 2015 Dec 10.

PMID:
26661409
8.

Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbidities.

Haake SM, Brooks SA, Welsh E, Fulp WJ, Chen DT, Dhillon J, Haura E, Sexton W, Spiess PE, Pow-Sang J, Rathmell WK, Fishman M.

Urol Oncol. 2016 Mar;34(3):122.e1-7. doi: 10.1016/j.urolonc.2015.09.015. Epub 2015 Nov 3.

9.

Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma.

Schabath MB, Welsh EA, Fulp WJ, Chen L, Teer JK, Thompson ZJ, Engel BE, Xie M, Berglund AE, Creelan BC, Antonia SJ, Gray JE, Eschrich SA, Chen DT, Cress WD, Haura EB, Beg AA.

Oncogene. 2016 Jun 16;35(24):3209-16. doi: 10.1038/onc.2015.375. Epub 2015 Oct 19.

10.

Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.

Torres-Roca JF, Fulp WJ, Caudell JJ, Servant N, Bollet MA, van de Vijver M, Naghavi AO, Harris EE, Eschrich SA.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):631-8. doi: 10.1016/j.ijrobp.2015.06.021. Epub 2015 Jun 25.

11.

The radiosensitivity index predicts for overall survival in glioblastoma.

Ahmed KA, Chinnaiyan P, Fulp WJ, Eschrich S, Torres-Roca JF, Caudell JJ.

Oncotarget. 2015 Oct 27;6(33):34414-22. doi: 10.18632/oncotarget.5437.

12.

Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Permuth-Wey J, Chen DT, Fulp WJ, Yoder SJ, Zhang Y, Georgeades C, Husain K, Centeno BA, Magliocco AM, Coppola D, Malafa M.

Cancer Prev Res (Phila). 2015 Sep;8(9):826-34. doi: 10.1158/1940-6207.CAPR-15-0094.

13.

STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.

Permuth-Wey J, Fulp WJ, Reid BM, Chen Z, Georgeades C, Cheng JQ, Magliocco A, Chen DT, Lancaster JM.

Int J Cancer. 2016 Feb 1;138(3):612-9. doi: 10.1002/ijc.29799. Epub 2015 Aug 28.

14.

Outcomes with and without axillary node dissection for node-positive lumpectomy and mastectomy patients.

Snow R, Reyna C, Johns C, Lee MC, Sun W, Fulp WJ, Kiluk JV, Laronga C.

Am J Surg. 2015 Oct;210(4):685-93. doi: 10.1016/j.amjsurg.2015.05.004. Epub 2015 Jun 26.

PMID:
26210706
15.

Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer.

Suleiman Y, Mahipal A, Shibata D, Siegel EM, Jump H, Fulp WJ, Springett GM, Kim R.

Cancer Chemother Pharmacol. 2015 Sep;76(3):481-7. doi: 10.1007/s00280-015-2814-8. Epub 2015 Jul 1.

PMID:
26126727
16.

Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study.

Sudenga SL, Ingles DJ, Pierce Campbell CM, Lin HY, Fulp WJ, Messina JL, Stoler MH, Abrahamsen M, Villa LL, Lazcano-Ponce E, Giuliano AR.

Eur Urol. 2016 Jan;69(1):166-73. doi: 10.1016/j.eururo.2015.05.032. Epub 2015 Jun 6.

17.

Use of Adjuvant Cisplatin-Based Versus Carboplatin-Based Chemotherapy in Non-Small-Cell Lung Cancer: Findings From the Florida Initiative for Quality Cancer Care.

Tanvetyanon T, Lee JH, Fulp WJ, Schreiber F, Brown RH, Levine RM, Cartwright TH, Abesada-Terk G, Kim GP, Alemany C, Faig D, Sharp PV, Markham MJ, Malafa M, Jacobsen PB.

J Oncol Pract. 2015 Jul;11(4):332-7. doi: 10.1200/JOP.2014.001750. Epub 2015 May 19.

PMID:
25991639
18.

Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection.

Ahmed KA, Fulp WJ, Berglund AE, Hoffe SE, Dilling TJ, Eschrich SA, Shridhar R, Torres-Roca JF.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):837-42. doi: 10.1016/j.ijrobp.2015.01.036. Epub 2015 Mar 30.

19.

A systematic review of the efficacy and safety experience reported for sorafenib in advanced renal cell carcinoma (RCC) in the post-approval setting.

Fishman MN, Tomshine J, Fulp WJ, Foreman PK.

PLoS One. 2015 Apr 1;10(4):e0120877. doi: 10.1371/journal.pone.0120877. eCollection 2015. Review.

20.

Outcomes of Therasphere Radioembolization for Colorectal Metastases.

Abbott AM, Kim R, Hoffe SE, Arslan B, Biebel B, Choi J, El-Haddad G, Kis B, Sweeney J, Meredith KL, Almhanna K, Strosberg J, Shibata D, Fulp WJ, Shridhar R.

Clin Colorectal Cancer. 2015 Sep;14(3):146-53. doi: 10.1016/j.clcc.2015.02.002. Epub 2015 Feb 16.

PMID:
25795047
21.

If you did not document it, it did not happen: rates of documentation of discussion of infertility risk in adolescent and young adult oncology patients' medical records.

Quinn GP, Block RG, Clayman ML, Kelvin J, Arvey SR, Lee JH, Reinecke J, Sehovic I, Jacobsen PB, Reed D, Gonzalez L, Vadaparampil ST, Laronga C, Lee MC, Pow-Sang J, Eggly S, Franklin A, Shah B, Fulp WJ, Hayes-Lattin B.

J Oncol Pract. 2015 Mar;11(2):137-44. doi: 10.1200/JOP.2014.000786. Epub 2014 Dec 30.

22.

Human papillomavirus virus (HPV) genotype- and age-specific analyses of external genital lesions among men in the HPV Infection in Men (HIM) Study.

Ingles DJ, Pierce Campbell CM, Messina JA, Stoler MH, Lin HY, Fulp WJ, Abrahamsen M, Sirak BA, O'Keefe MT, Papenfuss M, Gage C, Carvalho da Silva R, Gonzalez Sosa R, Rojas Juarez O, Villa LL, Lazcano Ponce E, Giuliano AR.

J Infect Dis. 2015 Apr 1;211(7):1060-7. doi: 10.1093/infdis/jiu587. Epub 2014 Oct 24.

23.

Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer.

Pimiento JM, Chen DT, Centeno BA, Davis-Yadley AH, Husain K, Fulp WJ, Wang C, Zhang A, Malafa MP.

Pancreas. 2015 Jan;44(1):122-7. doi: 10.1097/MPA.0000000000000218.

24.

Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas.

Coppola D, Balducci L, Chen DT, Loboda A, Nebozhyn M, Staller A, Fulp WJ, Dalton W, Yeatman T, Brem S.

J Geriatr Oncol. 2014 Oct 1;5(4):389-99. doi: 10.1016/j.jgo.2014.08.003. Epub 2014 Sep 11.

PMID:
25220188
25.

Prospective study of seroreactivity to JC virus T-antigen and risk of colorectal cancers and adenomas.

Hampras SS, Viscidi RP, Helzlsouer KJ, Lee JH, Fulp WJ, Giuliano AR, Platz EA, Rollison DE.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2591-6. doi: 10.1158/1055-9965.EPI-14-0370. Epub 2014 Aug 15.

26.

Florida Initiative for Quality Cancer Care: improvements in breast cancer quality indicators during a 3-year interval.

Laronga C, Gray JE, Siegel EM, Lee JH, Fulp WJ, Fletcher M, Schreiber F, Brown R, Levine R, Cartwright T, Abesada-Terk G Jr, Kim G, Alemany C, Faig D, Sharp P, Markham MJ, Shibata D, Malafa M, Jacobsen PB.

J Am Coll Surg. 2014 Oct;219(4):638-45.e1. doi: 10.1016/j.jamcollsurg.2014.03.063. Epub 2014 Jul 1.

27.

Carboplatin and paclitaxel treatment is effective in advanced anal cancer.

Kim R, Byer J, Fulp WJ, Mahipal A, Dinwoodie W, Shibata D.

Oncology. 2014;87(2):125-32. doi: 10.1159/000361051. Epub 2014 Jul 8.

PMID:
25012155
28.

Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience.

Wong J, Fulp WJ, Strosberg JR, Kvols LK, Centeno BA, Hodul PJ.

Am J Surg. 2014 Nov;208(5):775-780. doi: 10.1016/j.amjsurg.2014.04.003. Epub 2014 Jun 8.

PMID:
24997491
29.

The impact of pathologic nodal status on survival following neoadjuvant chemoradiation for locally advanced rectal cancer.

Hernandez JM, Clark W, Weber J, Fulp WJ, Lange L, Shibata D.

Int J Colorectal Dis. 2014 Sep;29(9):1061-8. doi: 10.1007/s00384-014-1917-8. Epub 2014 Jun 27.

PMID:
24970021
30.

Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.

Shridhar R, Freilich J, Hoffe SE, Almhanna K, Fulp WJ, Yue B, Karl RC, Meredith K.

Ann Surg Oncol. 2014 Nov;21(12):3744-50. doi: 10.1245/s10434-014-3795-2. Epub 2014 May 23.

PMID:
24854492
31.

Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes.

Komrokji RS, Padron E, Yu D, Fulp WJ, Rodriguez Y, Tinsley S, List AF, Lancet JE.

Am J Hematol. 2014 Aug;89(8):809-12. doi: 10.1002/ajh.23749. Epub 2014 May 16.

32.

Changes in the care of non-small-cell lung cancer after audit and feedback: the Florida initiative for quality cancer care.

Tanvetyanon T, Lee JH, Fulp WJ, Schreiber F, Brown RH, Levine RM, Cartwright TH, Abesada-Terk G Jr, Kim GP, Alemany C, Faig D, Sharp PV, Markham MJ, Malafa M, Jacobsen PB.

J Oncol Pract. 2014 Jul;10(4):e247-54. doi: 10.1200/JOP.2013.001275. Epub 2014 Apr 15.

PMID:
24737876
33.

A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction.

Komrokji RS, Mailloux AW, Chen DT, Sekeres MA, Paquette R, Fulp WJ, Sugimori C, Paleveda-Pena J, Maciejewski JP, List AF, Epling-Burnette PK.

Haematologica. 2014 Jul;99(7):1176-83. doi: 10.3324/haematol.2012.083345. Epub 2014 Jan 31.

34.

Adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy.

Mellon EA, Springett GM, Hoffe SE, Hodul P, Malafa MP, Meredith KL, Fulp WJ, Zhao X, Shridhar R.

Cancer. 2014 Apr 15;120(8):1171-7. doi: 10.1002/cncr.28543. Epub 2014 Jan 3.

35.

The role of monogamy and duration of heterosexual relationships in human papillomavirus transmission.

Nyitray AG, Lin HY, Fulp WJ, Chang M, Menezes L, Lu B, Abrahamsen M, Papenfuss M, Gage C, Galindo CM, Giuliano AR.

J Infect Dis. 2014 Apr 1;209(7):1007-15. doi: 10.1093/infdis/jit615. Epub 2013 Nov 18.

36.

A prospective analysis of smoking and human papillomavirus infection among men in the HPV in Men Study.

Schabath MB, Villa LL, Lin HY, Fulp WJ, Lazcano-Ponce E, Salmerón J, Abrahamsen ME, Papenfuss MR, Quiterio M, Giuliano AR.

Int J Cancer. 2014 May 15;134(10):2448-57. doi: 10.1002/ijc.28567. Epub 2013 Nov 13.

37.

TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients.

Caceres G, McGraw K, Yip BH, Pellagatti A, Johnson J, Zhang L, Liu K, Zhang LM, Fulp WJ, Lee JH, Al Ali NH, Basiorka A, Smith LJ, Daugherty FJ, Littleton N, Wells RA, Sokol L, Wei S, Komrokji RS, Boultwood J, List AF.

Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16127-32. doi: 10.1073/pnas.1311055110. Epub 2013 Sep 16.

38.

Racial differences in the incidence and clearance of human papilloma virus (HPV): the HPV in men (HIM) study.

Schabath MB, Villa LL, Lin HY, Fulp WJ, Akogbe GO, Abrahamsen ME, Papenfuss MR, Lazcano-Ponce E, Salmerón J, Quiterio M, Giuliano AR.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1762-70. doi: 10.1158/1055-9965.EPI-13-0303. Epub 2013 Jul 19.

39.

Cutaneous angiosarcoma: a single-institution experience.

Perez MC, Padhya TA, Messina JL, Jackson RS, Gonzalez RJ, Bui MM, Letson GD, Cruse CW, Lavey RS, Cheong D, Forster MR, Fulp WJ, Sondak VK, Zager JS.

Ann Surg Oncol. 2013 Oct;20(11):3391-7. doi: 10.1245/s10434-013-3083-6. Epub 2013 Jul 9.

40.

Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance.

Hopewell EL, Zhao W, Fulp WJ, Bronk CC, Lopez AS, Massengill M, Antonia S, Celis E, Haura EB, Enkemann SA, Chen DT, Beg AA.

J Clin Invest. 2013 Jun;123(6):2509-22. doi: 10.1172/JCI67250. Epub 2013 May 1.

41.

Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma.

Anic GM, Sondak VK, Messina JL, Fenske NA, Zager JS, Cherpelis BS, Lee JH, Fulp WJ, Epling-Burnette PK, Park JY, Rollison DE.

Cancer Epidemiol. 2013 Aug;37(4):434-9. doi: 10.1016/j.canep.2013.02.010. Epub 2013 Mar 21.

42.

Sequelae of fat grafting postmastectomy: an algorithm for management of fat necrosis.

Doren EL, Parikh RP, Laronga C, Hiro ME, Sun W, Lee MC, Smith PD, Fulp WJ.

Eplasty. 2012;12:e53. Epub 2012 Dec 4.

43.

Nicotine induces inhibitor of differentiation-1 in a Src-dependent pathway promoting metastasis and chemoresistance in pancreatic adenocarcinoma.

Treviño JG, Pillai S, Kunigal S, Singh S, Fulp WJ, Centeno BA, Chellappan SP.

Neoplasia. 2012 Dec;14(12):1102-14.

44.

Prolonged survival and delayed progression of pancreatic intraepithelial neoplasia in LSL-KrasG12D/+;Pdx-1-Cre mice by vitamin E δ-tocotrienol.

Husain K, Centeno BA, Chen DT, Fulp WJ, Perez M, Zhang Lee G, Luetteke N, Hingorani SR, Sebti SM, Malafa MP.

Carcinogenesis. 2013 Apr;34(4):858-63. doi: 10.1093/carcin/bgt002. Epub 2013 Jan 9.

45.

Prognostic factors for survival after complete resections of synchronous lung cancers in multiple lobes: pooled analysis based on individual patient data.

Tanvetyanon T, Finley DJ, Fabian T, Riquet M, Voltolini L, Kocaturk C, Fulp WJ, Cerfolio RJ, Park BJ, Robinson LA.

Ann Oncol. 2013 Apr;24(4):889-94. doi: 10.1093/annonc/mds495. Epub 2012 Nov 7. Review.

PMID:
23136230
46.

Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions.

Chen L, Chen DT, Kurtyka C, Rawal B, Fulp WJ, Haura EB, Cress WD.

J Biol Chem. 2012 Nov 23;287(48):40106-18. doi: 10.1074/jbc.M112.380865. Epub 2012 Oct 11.

47.

A cluster randomized trial evaluating the efficacy of patient navigation in improving quality of diagnostic care for patients with breast or colorectal cancer abnormalities.

Wells KJ, Lee JH, Calcano ER, Meade CD, Rivera M, Fulp WJ, Roetzheim RG.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1664-72. doi: 10.1158/1055-9965.EPI-12-0448.

48.

Validation of a radiosensitivity molecular signature in breast cancer.

Eschrich SA, Fulp WJ, Pawitan Y, Foekens JA, Smid M, Martens JW, Echevarria M, Kamath V, Lee JH, Harris EE, Bergh J, Torres-Roca JF.

Clin Cancer Res. 2012 Sep 15;18(18):5134-43. Epub 2012 Jul 25.

49.

Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial.

Jacobsen PB, Wells KJ, Meade CD, Quinn GP, Lee JH, Fulp WJ, Gray JE, Baz RC, Springett GM, Levine RM, Markham MJ, Schreiber FJ, Cartwright TH, Burke JM, Siegel RD, Malafa MP, Sullivan D.

J Clin Oncol. 2012 Jul 10;30(20):2516-21. doi: 10.1200/JCO.2011.39.5186. Epub 2012 May 21.

50.

Quality of care in non-small-cell lung cancer: findings from 11 oncology practices in Florida.

Tanvetyanon T, Corman M, Lee JH, Fulp WJ, Schreiber F, Brown RH, Levine RM, Cartwright TH, Abesada-Terk G, Kim GP, Alemany C, Faig D, Sharp PV, Markham MJ, Bepler G, Siegel E, Shibata D, Malafa M, Jacobsen PB.

J Oncol Pract. 2011 Nov;7(6):e25-31.

Supplemental Content

Support Center